A important advancement in diabetes care is emerging with the introduction of tirzepatide at a dosage of 45mg. This new version builds upon the existing success of tirzepatide, a dual GIP and GLP-1 receptor, and https://210list.com/story22098809/groundbreaking-approach-tirzepatide-dose-for-diabetes-control